Location History:
- Groton, CT (US) (1981)
- Waterford, CT (US) (1976 - 1985)
Company Filing History:
Years Active: 1976-1985
Title: The Innovative Contributions of Charles A. Harbert in Pharmaceutical Patents
Introduction
Charles A. Harbert, based in Waterford, CT, is a prominent inventor known for his significant contributions in the field of pharmaceuticals. With a remarkable portfolio of 36 patents, Harbert has dedicated his career to developing innovative antidepressant agents, among other pharmaceutical advancements. His work not only underscores his inventive prowess but also highlights his commitment to addressing mental health challenges through chemistry.
Latest Patents
Harbert's recent patents focus on novel derivatives of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine. These compounds are recognized for their potential as effective antidepressants. His first significant patent details trans-isomeric derivatives that function by blocking the synaptosomal uptake of norepinephrine and serotonin, facilitating the alleviation of disruptions at central receptor sites. The preferred embodiment cited is the enantiomer trans-(1R)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its pharmaceutically acceptable acid addition salts.
In addition, Harbert has developed cis-isomeric derivatives of the same compound, which specifically target serotonin uptake, further correcting abnormalities at central receptor sites. The highlighted embodiment for this patent includes the enantiomer cis-(1S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine, also accompanied by its acceptable acid addition salts.
Career Highlights
Throughout his career, Charles A. Harbert has worked with leading pharmaceutical corporations such as Pfizer and Bayer. These affiliations represent a significant chapter in his professional journey where his inventive approaches have contributed to the advancements in medications that address mental health concerns. His expertise and innovative mindset have enabled him to stand out in a competitive landscape, leading to numerous patent applications.
Collaborations
Collaborating with esteemed peers such as Michael Ross Johnson and Lawrence S. Melvin, Jr., Harbert has fostered valuable partnerships that bolster the research and development processes within the pharmaceutical realm. These collaborations not only enrich the innovation pipeline but also facilitate the exchange of ideas that can lead to groundbreaking therapeutic solutions.
Conclusion
In conclusion, Charles A. Harbert exemplifies the spirit of innovation in pharmaceutical sciences. His extensive patent portfolio reflects a deep commitment to enhancing mental health treatment through chemical innovations. As the industry continues to evolve, the contributions of inventors like Harbert remain pivotal in paving the way for future advancements in health and well-being.